Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenothiazine hydrochloride is the hydrochloride salt of phenothiazine, a tricyclic compound that served as the prototype for the phenothiazine class of antipsychotic drugs. Unlike its later derivatives such as chlorpromazine, the parent phenothiazine compound lacks significant neuroleptic activity and was primarily utilized in the mid-20th century as an anthelmintic and insecticide. Its mechanism of action in parasites involves the inhibition of acetylcholinesterase and interference with the mitochondrial respiratory chain, specifically targeting NADH dehydrogenase, which leads to neuromuscular paralysis and death of the helminths. In human medicine, it was briefly used as a urinary antiseptic and for the treatment of pinworm and threadworm infections, but its use was discontinued due to adverse effects such as hemolytic anemia and photosensitization. Today, it remains primarily of historical interest in human pharmacology and has been largely replaced by more effective and less toxic agents in veterinary practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phenothiazine hydrochloride.